GLUCOSAMINE - An Exclusive Market Insight Report Update

As a result of the US anti-dumping action against shrimp shells from India and the EU ban on seafood imports from China, there was a steep rise in the price of Glucosamine.

Hyderabad, India (prHWY.com) May 8, 2012 - April 18, 2012- RI Technologies' (http://www.researchimpact.com/) market insight report on Glucosamine analyzes the market by Type and Application at global level and for each of the geographic regions - North America, Europe, China, Asia-Pacific, and Rest of World. The Glucosamine market is segmented by Type into D-Glucosamine and N-Acetyl-Glucosamine; and by Application into Nutraceutical/Pharmaceutical, Feed Additives, and Food Ingredients. Global market by Volume in Metric Tons and Value in US$ is also included. Business profiles of 49 major companies are discussed in the report. The report serves as a guide to Glucosamine industry covering more than 240 companies that are engaged in Glucosamine R&D, processing, production, and distribution. Information related to recent product releases, product developments, partnerships, collaborations, mergers and acquisitions, ethical issues, regulatory affairs, and other areas of concern is also covered in the report. Compilation of Worldwide Patents and Research related to Glucosamine is also provided. Estimations and predictions are graphically illustrated by 202 exclusive exhibits for all geographic regions.

Glucosamine is a material that naturally occurs in the joints of the body. It is synthesized by the body from glucose (sugar) and glutamine. Glucosamine helps in making and repairing cartilage in the body. As humans grow old, the ability of the body to produce Glucosamine from glucose and glutamine also declines due to a decrease in the enzyme that aids production of Glucosamine. When Glucosamine Sulfate is not available in sufficient quantities, there is a degeneration of the cartilage. Glucosamine supplements could restore the Glucosamine levels in the body and also repair joints that are destroyed by osteoarthritis or other wounds.

Global volume market for Glucosamine was reported at US$ 2.879 thousand metric tons in 2000. Glucosamine based products were classified as nutraceuticals in most countries worldwide. But now a number of countries (especially Europe) are permitting glucosamine products to be registered as pharmaceuticals. Products sold as drugs need to be approved by national medicines agencies, whereas nutraceuticals in general are governed by much less demanding food regulations. As a result of the US anti-dumping action against shrimp shells from India and the EU ban on seafood imports from China, there was a steep rise in the price of Glucosamine. But since the uplift of the ban price of glucosamine has more or less stabilized. Change in the status of Glucosamine from drug to food has led to the market being opened up. Since its entrance on the food market, glucosamine has tripled in sales. The recommended dose of glucosamine is 1,500mg. Putting that level into food may cause an issue, due to its taste and also the expense.


The introduction of combination products such as Vitabiotics' Jointace [supplement] with collagen, glucosamine and chondroitin are undercutting sales for single glucosamine dietary supplements on the market. Glucosamine is traditionally sourced from shellfish, but one of the interesting areas in this field is the launch of vegetarian versions. Clearly, this opens up the supplement to a wider target market, and in addition prices are relatively stable compared to shellfish.

About RI Technologies

RI Technologies is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.

###

Tag Words: glucosamine

Categories: Research

Press Release Contact
Customer Support: contactus@researchimpact.com. Call us at INDIA: +91 9676994272 / UK: 076-24-057837 for your biotechnology and healthcare market research report requirements. We provide 24/7 online.

Link To This Press Release:

URL HTML Code